|
Teva’s New Leadership Decides Not to Enter Generic Lipitor Market
A flood of Lipitor generics hit the market last week, but Teva, the world’s largest generic-drug maker, decided a better strategy is not to sell what was once the world’s best-selling drug — at least not yet.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives